According to Huayuan Biotech's announcement, the company recently obtained a “Drug Production License” issued by the Zhejiang Drug Administration. The license code is Zhejiang 20260010, which is valid until August 9, 2031. This is the first time that the company has obtained this certificate and passed the drug GMP compliance test, providing qualification guarantees for product marketing and commercial production and sales, which is conducive to improving the layout of the entire vitamin D3 industry chain. However, the company still needs to obtain an API registration certificate. There is no significant impact on performance in the short term. Production and sales are affected by policy, market and other factors, and there is uncertainty.

According to Huayuan Biotech's announcement, the company recently obtained a “Drug Production License” issued by the Zhejiang Drug Administration. The license code is Zhejiang 20260010, which is valid until August 9, 2031. This is the first time that the company has obtained this certificate and passed the drug GMP compliance test, providing qualification guarantees for product marketing and commercial production and sales, which is conducive to improving the layout of the entire vitamin D3 industry chain. However, the company still needs to obtain an API registration certificate. There is no significant impact on performance in the short term. Production and sales are affected by policy, market and other factors, and there is uncertainty.